Hospital & Health Care - , ,
Founded in 2010, CardioGenomix provides genetic testing services to physicians for their cardiovascular patients. Initially focused on pharmacogenomic testing for Plavix (2C19), the company expanded the menu of options to include the 2D6 (beta blockers) and 2C9/VKORC1 (warfarin) assays in addition to tests such as Factor II, Factor V and others.